Compare Johnson & Johnson (JNJ) vs Western Union Co (WU) Price & Performance

Johnson & Johnson (JNJ) trades at $249.58, down 1.37% today, amid a generally bullish technical outlook with strong moving average signals. The company reported robust Q2 2026 earnings, beating EPS estimates and raising full-year guidance, with revenue growth to $94.19B in 2025 and a net income margin of 21.48%. Recent news highlights strong institutional interest and positive analyst sentiment, though the stock faces pressure from MedTech segment misses despite overall strength.

The outlook for JNJ remains positive, supported by solid fundamentals, a consistent dividend history, and upward revised earnings guidance. Key risks include competitive pressures in pharmaceuticals, regulatory hurdles, and execution challenges in the MedTech division. With a consensus price target of $279.33, representing ~12% upside, the stock offers a compelling opportunity for long-term investors, balanced by sector-specific volatility and macroeconomic factors.

Western Union (WU) trades at $8.65, down 2.59% on the day, with strong valuation metrics including a P/E of 6.53 and P/S of 0.71. The company maintains profitability with a 10.88% net margin and 47.66% ROE, though Q1 2026 earnings missed expectations. Recent developments include strategic partnerships with Total Wireless and Bybit, and the pending acquisition of Intermex. Technical indicators show mixed signals with bullish moving averages but overbought RSI levels.

WU presents a value opportunity with attractive dividend yield and low valuation multiples, but faces revenue decline and margin pressure. The stock trades above analyst consensus target of $7.83, suggesting limited near-term upside. Key risks include declining traditional remittance business and execution challenges in digital transformation. Institutional sentiment remains cautious with only 12.5% buy ratings.